Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 15Leukemia 15Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Megakaryoblastic, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 7Congenital Abnormalities 7Prostatic Neoplasms 6Breast Neoplasms 6Myelodysplastic Syndromes 4Anemia, Refractory, with Excess of Blasts 4Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Burkitt Lymphoma 2Sarcoma, Myeloid 1Ovarian Neoplasms 1Neutropenia 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Amifostine 9Radiotherapy 6Cisplatin 5Paclitaxel 4Etoposide 3Cyclophosphamide 3Carboplatin 3sargramostim 1lometrexol 1denileukin diftitox 1Thiotepa 1Taxes 1Silymarin 1Radiation 1Pyridostigmine Bromide 1Phenobarbital 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Irinotecan 1Ifosfamide 1Idarubicin 1Folic Acid 1Filgrastim 1Fibroblast Growth Factor 7 1Docetaxel 1Dexamethasone 1Cytarabine 1Cyclosporine 1Bleomycin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Drug-Related Side Effects and Adverse Reactions × Mitoxantrone × Clear all
NCT00003068 2013-01-31

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡